BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24064459)

  • 1. Cofactoring and dimerization of proteinase-activated receptors.
    Lin H; Liu AP; Smith TH; Trejo J
    Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of protease-activated receptor signaling.
    Canto I; Soh UJ; Trejo J
    Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.
    O'Brien PJ; Prevost N; Molino M; Hollinger MK; Woolkalis MJ; Woulfe DS; Brass LF
    J Biol Chem; 2000 May; 275(18):13502-9. PubMed ID: 10788464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosomal signaling by protease-activated receptors.
    Grimsey N; Lin H; Trejo J
    Methods Enzymol; 2014; 535():389-401. PubMed ID: 24377935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
    Trejo J
    J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
    Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
    Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).
    Thibeault PE; LeSarge JC; Arends D; Fernandes M; Chidiac P; Stathopulos PB; Luyt LG; Ramachandran R
    J Biol Chem; 2020 Feb; 295(8):2520-2540. PubMed ID: 31892516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.
    Lin H; Trejo J
    J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.
    Gieseler F; Ungefroren H; Settmacher U; Hollenberg MD; Kaufmann R
    Cell Commun Signal; 2013 Nov; 11():86. PubMed ID: 24215724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors in hemostasis.
    Nieman MT
    Blood; 2016 Jul; 128(2):169-77. PubMed ID: 27127302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The domino effect triggered by the tethered ligand of the protease activated receptors.
    Han X; Nieman MT
    Thromb Res; 2020 Dec; 196():87-98. PubMed ID: 32853981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
    Miike S; McWilliam AS; Kita H
    J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the protease thrombin talks to cells.
    Coughlin SR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.
    French SL; Paramitha AC; Moon MJ; Dickins RA; Hamilton JR
    PLoS One; 2016; 11(10):e0165565. PubMed ID: 27788223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability.
    Heuberger DM; Franchini AG; Madon J; Schuepbach RA
    Thromb Res; 2019 May; 177():91-101. PubMed ID: 30861432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.